UBS Maintains Neutral on ArcBest, Raises Price Target to $145

Benzinga Newsdesk www.benzinga.com Neutral 51.9%

Neg 0% Neu 51.9% Pos 0%

UBS analyst Thomas Wadewitz maintains ArcBest (NASDAQ:ARCB) with a Neutral and raises the price target from $122 to $145.